文献速递肾小球疾病慢性肾脏病

患者对参与基于肾活检研究的态度的调查

A Survey of Patient Attitudes Toward Participation in Biopsy-Based Kidney Research.
PubMed 文献 · Kidney Int Rep · 2017-11-20

该调查评估了曾因临床需要接受肾活检的患者对捐献肾组织用于研究的态度。在117名参与者中,73%愿意在临床指征活检时增加穿刺针次以捐献组织,20%愿意仅因研究目的接受活检。年龄≥65岁和非裔美国患者允许额外穿刺的 odds 较低,但自报活检并发症不影响意愿。

要点

  • 多数曾接受肾活检的患者愿意在临床活检时额外穿刺捐献组织用于研究。
  • 仅少数患者愿意仅因研究目的接受肾活检。
  • 年龄≥65岁和非裔美国患者允许额外穿刺的意愿较低。

核心结论

  • 在曾接受肾活检的患者中,多数愿意在未来的临床指征活检中增加穿刺针次以捐献肾组织用于研究,少数愿意仅因研究目的接受活检。

研究设计与样本

  • 对曾因临床指征接受肾活检的参与者进行问卷调查,活检后中位9个月(四分位距5-13个月)开展。
  • 共联系177名参与者,117名(66%)完成调查。

主要发现

  • 85名参与者(73%)报告愿意在临床指征活检时允许额外穿刺针次以捐献肾组织用于研究。
  • 参与者参与研究的理由包括希望帮助他人、贡献科学以及参与研究无额外负担。
  • 多变量logistic模型显示,年龄≥65岁(vs ≤40岁)允许额外穿刺的OR为0.15(95%CI 0.03-0.73),非裔美国人(vs 所有其他)OR为0.15(95%CI 0.05-0.44)。
  • 参与者自报的活检并发症如疼痛、焦虑和血尿不影响允许额外穿刺的意愿。
  • 23名参与者(20%)表示即使没有临床指征也同意接受研究性活检。

临床怎么用

  • 肾内科医生在临床活检时可向患者说明额外穿刺用于研究的可能性,多数患者可能愿意捐献组织。
  • 对于年龄≥65岁和非裔美国患者,需注意其允许额外穿刺的意愿可能较低,应个体化沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: As part of the precision medicine initiative, the National Institutes of Health/National Institute of Diabetes and Digestive Kidney Diseases has proposed collecting human kidney tissue to discover novel therapeutic targets from patients with kidney diseases. Patient attitudes on participating in kidney biopsy-based research are largely unknown. METHODS: We evaluated attitudes toward donating kidney tissue to research among participants who had experienced a clinically indicated kidney biopsy, through a survey conducted 9 months (interquartile range, 5-13 months) after their biopsy. RESULTS: Of the 177 participants contacted, 117 (66%) participated in the survey. A total of 85 participants (73%) reported that they would allow additional needle passes during a clinically indicated biopsy to donate kidney tissue for research. As reasons for participating in such a study, the participants reported the desire to help others and to contribute to science, and the lack of additional burden while participating in such a study. In a multivariable logistic model, older and African American participants had lower odds of allowing an additional pass for research (odds ratio: age ≥65 years [vs. ≤40], 0.15 [95% confidence interval, 0.03-0.73]; African Americans (vs. all others), 0.15 [95% confidence interval, 0.05-0.44]). However, participants' self-reported biopsy complications such as pain, anxiety, and hematuria did not affect their willingness to allow additional passes. A total of 23 participants (20%) stated that they would agree to undergo a biopsy for research even if it was not clinically indicated. CONCLUSION: Among patients who had experienced a kidney biopsy, a majority were amenable to additional needle passes to donate kidney tissue for research during a future, clinically indicated biopsy, whereas a minority would undergo a biopsy for research purpose only.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Moledina DG, Cheung B, Kukova L, et al. A Survey of Patient Attitudes Toward Participation in Biopsy-Based Kidney Research. Kidney Int Rep. 2017. PMID: 29725645. doi:10.1016/j.ekir.2017.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。